Content by German Institute for Quality and Efficiency in Health Care (IQWiG)
|3 min read
Antibody-Drug Conjugate Benefits HER2-Low Breast Cancers
Patients with HER2-low breast cancers were included in the clinical trial proving the efficacy of trastuzumab deruxtecan monotherapy|2 min read
Single-Arm Trials May Not Be Effective in Drug Development
Experts urge EMA to prioritize evidence-based drug development over accelerated marketing authorizationPage 1 of 1





